A boutique advisory firm dedicated exclusively to healthcare companies seeking strategic investor engagement and capital solutions.
Brittany Financial is a boutique advisory firm dedicated exclusively to the healthcare sector. We combine deep industry knowledge with capital markets expertise to help companies navigate the complex landscape of investor relations and capital formation.
Our focused approach means we understand the unique challenges facing healthcare companies— from diagnostics and biotechnology to medical technology and digital health. This specialized knowledge allows us to deliver tailored strategies that resonate with the right investors.
15+
Years Experience
$2B+
Capital Raised
50+
Transactions
Sector Specialization
Deep expertise in healthcare capital markets
Strategic Partnership
Long-term client relationships
Data-Driven Insights
Intelligence-led communications
Execution Excellence
Proven track record of results
David Holmes brings deep healthcare capital markets expertise and a proven track record of delivering exceptional results for healthcare companies.
Founder & Managing Partner
David Holmes brings more than 15 years of experience in corporate finance and investor relations, with a specialized focus on the healthcare sector, including life science tools, diagnostics, and biotechnology. His expertise in capital markets and strategic communications has enabled him to design and execute comprehensive investor relations and capital advisory programs for companies operating in oncology, molecular diagnostics, and liquid biopsy over the past decade.
Prior to founding Brittany Financial, David served as Managing Director within the Diagnostics & Life Science Tools practice at The Gilmartin Group in New York. Before joining Gilmartin, he was a Director at LifeSci Advisors, where he worked with both public and private companies across the medtech, diagnostics, and life science tools sectors. At these leading investor relations firms, David advised clients on corporate positioning, investor targeting, and capital markets strategy, supporting companies through multiple stages of growth and financing.
David's experience across investment banking, diagnostics, and investor relations uniquely positions him to advise healthcare companies navigating complex capital markets and evolving commercial landscapes.
We have successfully executed a wide range of transactions across the healthcare sector, from early-stage capital raises to strategic M&A transactions.
Equity and debt financing, private placements, and public offerings for growth-stage healthcare companies.
Strategic advisory on mergers, acquisitions, and partnerships for healthcare companies at all stages.
Comprehensive IR programs including messaging, earnings support, and institutional investor engagement.
Market research, competitive benchmarking, and investor perception studies across healthcare verticals.
$2B+
Capital Raised
50+
Transactions
100+
IR Programs
15+
Years Serving Healthcare
Our extensive network spans institutional investors, family offices, hedge funds, and strategic acquirers across the healthcare sector.
US
Primary Market
Europe
Key Secondary
Asia
Growing Presence
We take a fundamentally different approach to healthcare advisory—one that combines deep sector expertise with personalized service and measurable results.
Unlike generalist firms, we focus exclusively on healthcare. This specialization means we understand the nuances of different sub-sectors—from diagnostics to digital health—and know which investors are active in each space.
Our boutique structure means every client works directly with senior professionals. You'll never be passed to junior analysts—we bring the full weight of our experience to every engagement.
We leverage proprietary market intelligence and analytics to develop strategies backed by data. Our recommendations are grounded in reality, not theory, ensuring measurable outcomes for our clients.
We build lasting relationships with our clients, not one-off transactions. Many of our clients have worked with us for years, trusting us as their ongoing strategic advisor for capital markets matters.